NICOLA HANANIA to Anti-Inflammatory Agents
This is a "connection" page, showing publications NICOLA HANANIA has written about Anti-Inflammatory Agents.
Connection Strength
2.207
-
Targeting IL-5 in COPD. Int J Chron Obstruct Pulmon Dis. 2019; 14:1045-1051.
Score: 0.507
-
Targeting airway inflammation in asthma: current and future therapies. Chest. 2008 Apr; 133(4):989-98.
Score: 0.235
-
The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD. Pulm Pharmacol Ther. 2008; 21(3):540-50.
Score: 0.231
-
Asthma in older adults. Clin Chest Med. 2007 Dec; 28(4):685-702, v.
Score: 0.229
-
Update on the pharmacologic therapy for chronic obstructive pulmonary disease. Clin Chest Med. 2007 Sep; 28(3):589-607, vi-vii.
Score: 0.225
-
Acute asthma in pregnancy. Crit Care Med. 2005 Oct; 33(10 Suppl):S319-24.
Score: 0.197
-
Anti-inflammatory activities of beta2-agonists. Curr Drug Targets Inflamm Allergy. 2004 Sep; 3(3):271-7.
Score: 0.183
-
The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD. Chest. 2003 Sep; 124(3):834-43.
Score: 0.171
-
Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol. 1995 Nov; 96(5 Pt 1):571-9.
Score: 0.099
-
Evaluating the safety of COPD medications: an evidence-based review. Chest. 2013 Oct; 144(4):1357-1367.
Score: 0.086
-
Novel Anti-Inflammatory Approaches to COPD. Int J Chron Obstruct Pulmon Dis. 2023; 18:1333-1352.
Score: 0.042